In our earlier studies with human breast cancer [7], [8], [9], we identified the potential roles of COX-2, VEGF-C and a diverse family of VEGF-C binding receptors for lymphangiogenesis and lympho-vascular invasion. The gene discussed is VEGFC; the disease is breast cancer.